Esperion Therapeutics Balance Sheet - Annual (NASDAQ:ESPR)

Add to My Stocks
$36.69 $0.69 (1.85%) ESPR stock closing price Apr 21, 2017 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Esperion Therapeutics, and helps in stock analysis. Financial strength can be guaged by performing Esperion Therapeutics stock analysis and by analyzing the balance sheet. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The Esperion Therapeutics balance sheet for 2016 shows total assets of $245.21M. View latest and last 10 year balance sheet data to check Esperion Therapeutics financial performance..

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011
Cash38.16M77.33M85.03M56.53M6.51M1.57M
Marketable Securities173.41M134.92M20.8M3.52M--
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets1.99M2.13M0.92M0.55M0.62M0.29M
Esperion Therapeutics Total Current Assets
213.57M214.39M106.76M60.61M7.13M1.86M
Property Plant & Equipment1.28M1.16M1.18M0.76M--
Accumulated Depreciation0.6M0.35M0.4M0.68M--
Esperion Therapeutics Net Property Plant & Equipment
0.67M0.8M0.78M0.08M0.12M0.25M
Investment & Advances30.9M80.31M35.74M17.53M--
Other Non-Current Assets------
Deferred Charges------
Intangibles0.05M0.05M0.05M0.05M0.05M0.05M
Deposits & Other Assets-----0.01M
Esperion Therapeutics Total Assets
245.21M295.57M143.34M78.29M7.31M2.17M
Notes Payable------
Accounts Payable4.59M0.7M2.04M2.23M0.47M0.69M
Current Portion Long-Term Debt1.7M1.6M0.63M-15.24M-
Current Portion Capital Leases------
Accrued Expenses9.28M3.31M2.81M1.97M1.19M0.2M
Income Taxes Payable------
Other Current Liabilities----0.26M0.44M
Esperion Therapeutics Total Current Liabilities
15.58M5.62M5.49M4.2M17.17M1.33M
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt1.02M2.68M4.29M-7.52M6.89M
Non-Current Capital Leases------
Other Long-Term Liabilities------
Esperion Therapeutics Total Liabilities
16.61M8.31M9.79M4.2M24.7M8.23M
Minority Interest------
Preferred Stock----23.97M23.97M
Common Stock Net0.02M0.02M0.02M0.01M--
Capital Surplus457.95M441.94M238.03M142.14M0.6M0.2M
Retained Earnings-229.2M-154.22M-104.43M-68.06M-41.97M-30.23M
Treasury Stock------
Other Liabilities-0.17M-0.48M-0.05M---
Esperion Therapeutics Shareholders Equity
228.6M287.25M133.55M74.09M-17.38M-30.03M
Esperion Therapeutics Total Liabilities & Shareholders Equity
245.21M295.57M143.34M78.29M7.31M2.17M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Balance sheet for another ticker

Most investors just check the Esperion Therapeutics stock price, and Esperion Therapeutics historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Esperion Therapeutics PE ratio chart. Below is a brief explanation of common balance sheet terms:
  • Assets: ESPR total assets, which was at $245.21M for 2016 is a balance sheet item representing value of what Esperion Therapeutics owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Esperion Therapeutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for ESPR stock stand at $16.61M.
.